BILL NUMBER: AB 1307	AMENDED
	BILL TEXT

	AMENDED IN ASSEMBLY  APRIL 22, 2009

INTRODUCED BY   Assembly Member Buchanan
    (   Coauthors:   Assembly Members 
 Portantino  and Torres   ) 

                        FEBRUARY 27, 2009

   An act to amend Section 125001 of the Health and Safety Code,
relating to newborn screening, and making an appropriation thereof.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 1307, as amended, Buchanan. Newborn genetic screening.
   Existing law requires that the State Department of Public Health
establish a statewide program for the screening of newborns for
specified genetic disorders, including tandem mass spectrometry
screening for fatty acid oxidation, amino acid, and organic acid
disorders and congenital adrenal hyperplasia. Existing law creates
the Genetic Disease Testing Fund in the State Treasury, which is used
to fund the newborn screening program.
   This bill would  , instead,  require  , prior
to January 1, 2011,  the statewide screening program to 
also  include all conditions recommended by the American College
of Medical Genetics  (ACMG)  as of January 1, 2010. 
This bill would also require the department to consider future
conditions recommended by the ACMG or other specified entities. The
department would be required to adopt the recommendations, as
specified, unless the department determines that the recommended
conditions are not necessary for advancing newborn health and
notifies appropriate committees of the Legislature of that
determination.  Because this bill would expand the purposes of
the screening program it constitutes an appropriation.
   Vote: majority. Appropriation: yes. Fiscal committee: yes.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  Section 125001 of the Health and Safety Code is amended
to read:
   125001.  (a) The department shall establish a program for the
development, provision, and evaluation of genetic disease testing,
and may provide laboratory testing facilities or make grants to,
contract with, or make payments to, any laboratory that it deems
qualified and cost-effective to conduct testing or with any metabolic
specialty clinic to provide necessary treatment with qualified
specialists. The program shall provide genetic screening and followup
services for persons who have the screening.
   (b)  (1)    The department shall  , 
 prior to January 1, 2011,  expand statewide screening of
newborns to include  tandem mass spectrometry screening for fatty
acid oxidation, amino acid, and organic acid disorders, and
congenital adrenal hyperplasia, as well as  all conditions
recommended by the American College of Medical Genetics  (ACMG)
 as of January 1, 2010  , as soon as possible 
. The department shall provide information with respect to these
disorders and available testing resources to all women receiving
prenatal care and to all women admitted to a hospital for delivery.
If the department is unable to provide this statewide screening by
August 1, 2005, the department shall temporarily obtain these testing
services through a competitive bid process from one or more public
or private laboratories that meet the department's requirements for
testing, quality assurance, and reporting. If the department
determines that contracting for these services is more
cost-effective, and meets the other requirements of this chapter,
than purchasing the tandem mass spectrometry equipment themselves,
the department shall contract with one or more public or private
laboratories. 
   (2) Commencing January 1, 2010, the department shall consider
additional conditions for screening, as recommended by the ACMG or
other governing body appointed to convene, discuss, and establish
recommendations for newborn screening programs and approved by the
United States Secretary of Health and Human Services. The department
shall adopt the recommended conditions for screening, within one year
of receipt of the recommendations, unless the department determines
that the screening for the recommended condition is not necessary for
advancing newborn health, and notifies the appropriate committees of
jurisdiction in the Legislature of this determination. 
   (c) The department shall report to the Legislature regarding the
progress of the program on or before July 1, 2006. The report shall
include the costs for screening, followup, and treatment as compared
to costs and morbidity averted for each condition tested for in the
program.